TNFalpha blockade in human diseases an overview of efficacy and safety

TNFalpha blockade in human diseases : an overview of efficacy and safety

Tumor necrosis factor-alpha (TNFalpha) antagonists including antibodies and soluble receptors have shown remarkable efficacy in various immune-mediated inflammatory diseases (IMID). As experience with these agents has matured, there is an emerging need to integrate and critically assess the utility...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 126(2008), 1 vom: 01. Jan., Seite 13-30
1. Verfasser: Lin, Jan (VerfasserIn)
Weitere Verfasser: Ziring, David, Desai, Sheetal, Kim, Sungjin, Wong, Maida, Korin, Yael, Braun, Jonathan, Reed, Elaine, Gjertson, David, Singh, Ram Raj
Format: Aufsatz
Sprache:English
Veröffentlicht: 2008
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review Anti-Inflammatory Agents, Non-Steroidal Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Immunoglobulin G Receptors, Tumor Necrosis Factor Tumor Necrosis Factor-alpha mehr... Infliximab B72HH48FLU Adalimumab FYS6T7F842 Etanercept OP401G7OJC